sever
acut
respiratori
syndromerel
coronaviru
result
pandem
continu
spread
quickli
around
globe
current
effect
vaccin
avail
prevent
intens
global
develop
activ
progress
context
differ
technolog
platform
face
sever
challeng
result
involv
new
viru
still
fulli
characteris
find
right
condit
viru
amplif
develop
vaccin
base
inactiv
attenu
whole
viral
particl
among
describ
establish
workflow
base
shotgun
tandem
mass
spectrometri
data
guid
optimis
condit
viral
amplif
parallel
analys
dynam
host
cell
proteom
follow
infect
provid
global
overview
biolog
process
modul
viru
could
explor
identifi
drug
target
address
pandem
authorfund
right
reserv
reus
allow
without
permiss
viru
caus
agent
sever
acut
respiratori
syndrom
spread
worldwid
within
week
start
decemb
wuhan
major
four
structur
gene
encod
nucleocapsid
protein
n
spike
protein
small
membran
protein
sm
membran
glycoprotein
addit
membran
glycoprotein
occur
betacoronavirus
base
speed
outbreak
develop
appear
spread
easili
human
popul
reproduct
number
viru
current
thought
around
suggest
potenti
sustain
humantohuman
transmiss
appear
respiratori
droplet
potenti
fecalor
rout
pandem
situat
one
outstand
question
concern
possibl
contain
spread
persist
human
popul
social
distanc
polici
lockdown
contain
measur
worldwid
implement
slow
spread
current
roadmap
lift
restrict
reli
deploy
effect
diagnost
therapi
eventu
develop
effect
vaccin
sever
platform
use
develop
vaccin
includ
spike
subunit
dna
rna
wholevirion
nanoparticl
vaccin
success
antivir
vaccin
employ
inactiv
attenu
whole
viral
particl
vaccin
antigen
depend
induct
neutral
antibodi
structur
protein
viru
howev
viru
yield
dedic
cell
cultur
system
could
rel
low
compar
quantiti
envis
requir
massiv
vaccin
product
addit
product
campaign
timeconsum
highli
demand
due
danger
work
pathogen
thu
optim
product
whole
viral
particl
antigen
utmost
interest
vaccin
concomitantli
vaccin
develop
better
understand
host
respond
infect
may
help
direct
therapeut
avenu
multipl
proteom
strategi
shown
insight
better
understand
coronaviru
structur
molecular
mechan
infect
tracheal
tissu
chicken
infect
infecti
bronchiti
coronaviru
analyz
malditof
tandem
mass
spectrometri
establish
host
respons
vero
cell
infect
porcin
epidem
diarrhea
viru
pedv
analyz
shotgun
proteom
differ
pedv
coronaviru
strain
compar
itraqlabel
quantit
approach
show
differ
inflammatori
cascad
elicit
dynam
host
protein
trigger
specif
overexpress
coronaviru
gene
also
establish
literatur
yet
avail
proteom
character
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
viru
sever
studi
interest
recent
submit
soon
avail
describ
establish
workflow
base
shotgun
tandem
mass
spectrometri
data
addit
gain
basic
inform
infect
aim
guid
optimis
condit
whole
viral
particl
antigen
product
aid
vaccin
develop
vero
atcc
cell
cultur
dulbecco
modifi
eagl
medium
dmem
themofish
supplement
fetal
calf
serum
fc
penicillinstreptomycin
cell
passag
trypsin
everi
day
strain
genbank
provid
lazzaro
spallanzani
nation
institut
infecti
diseas
rome
itali
via
evag
network
european
viru
archiv
goe
global
stock
use
experi
undergon
two
passag
vero
cell
store
viru
titer
determin
standard
plaqu
assay
pfuml
kinet
vero
cell
seed
cm
flask
grown
cell
confluenc
ml
dmem
supplement
fc
penicillinstreptomycin
one
night
infect
two
multipl
infect
moi
cell
harvest
day
post
infect
dpi
supernat
infect
cell
save
plaqu
assay
titrat
confirm
product
infecti
viral
particl
infect
vero
cell
microscop
observ
cytopath
effect
cpe
time
point
thermo
fisher
scientif
prior
ingel
trypsin
proteolysi
perform
describ
hartmann
et
al
peptid
identifi
use
ultim
nanolc
system
thermo
fisher
scientif
coupl
qexact
hf
mass
spectromet
thermo
fisher
scientif
peptid
desalt
reversedphas
pepmap
id
mm
thermo
fisher
scientif
peptid
separ
nanoscal
pepmap
nanolc
column
id
cm
thermo
fisher
scientif
flow
rate
per
min
use
min
gradient
compris
min
solvent
b
min
solvent
b
solvent
consist
formic
acid
water
solvent
b
acetonitril
formic
acid
water
mass
spectromet
oper
mode
full
ms
acquir
mz
abund
precursor
ion
select
fragment
dynam
exclus
time
ion
charg
select
msm
analysi
secondari
ion
isol
window
mz
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
msm
spectra
record
sampl
assign
peptid
sequenc
use
mascot
server
matrix
scienc
databas
sequenc
residu
contain
uniprot
chlorocebu
sequenc
download
march
protein
sequenc
queri
first
analysi
remov
contamin
spectra
inhous
common
contamin
databas
sequenc
residu
encompass
contamin
classic
observ
proteom
crap
addit
contamin
bo
tauru
sequenc
correspond
abund
protein
foetal
calf
serum
present
cell
cultur
medium
peptidetomsm
spectrum
assign
done
follow
paramet
full
trypsin
specif
maximum
two
miss
cleavag
mass
toler
parent
ion
ppm
higher
top
ion
score
protein
group
share
least
one
peptid
group
labelfre
quantif
base
psm
count
protein
follow
principl
parsimoni
protein
identifi
one
specif
peptid
retain
analysi
protein
fdr
mass
spectrometri
proteom
data
deposit
proteomexchang
consortium
via
pride
partner
repositori
dataset
identifi
princip
compon
analysi
done
previous
describ
coexpress
cluster
analysi
obtain
use
bioconductor
r
packag
coseq
protein
abund
matrix
use
input
coseqr
log
clrtransform
appli
matrix
normal
abund
protein
kmean
algorithm
chosen
detect
coexpress
cluster
across
differ
time
point
kmean
algorithm
repeat
time
order
determin
optim
number
cluster
result
number
cluster
run
record
parsimoni
cluster
partit
select
use
slope
heurist
approach
pca
coseq
analysi
perform
remov
protein
spectral
count
lower
three
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
host
protein
group
retain
final
protein
assign
differ
cluster
retain
cluster
visual
gene
ontolog
go
enrich
analysi
per
cluster
statist
enrich
fdr
go
term
protein
differenti
express
pairwis
sampl
protein
assign
coexpress
cluster
identifi
use
metascap
statist
enrich
go
term
visual
understand
dynam
associ
infect
determin
optim
condit
wholevir
particl
antigen
product
infect
vero
cell
two
multipl
infect
moi
monitor
kinet
infect
mean
tandem
mass
spectrometri
sever
day
figur
overal
identifi
vero
cell
protein
protein
uniqu
peptid
fdr
respect
tabl
accord
notabl
cytopath
effect
follow
intens
viru
replic
observ
cultur
timepoint
previous
report
expect
larger
varieti
peptid
found
overrepres
protein
figur
show
distribut
divers
across
time
point
three
abund
viral
protein
interestingli
increas
protein
level
reli
increas
abund
set
peptid
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
new
sequenc
regist
peak
viral
product
compar
earli
time
point
evalu
extent
viru
profil
obtain
tandem
mass
spectrometri
reflect
viru
product
measur
rna
molecul
quantit
pcr
analysi
across
time
point
figur
variat
abund
viral
protein
yield
reflect
variat
number
rna
molecul
confirm
lcmsm
labelfre
quantit
appli
monitor
infect
kinet
race
develop
vaccin
fight
global
spread
differ
technolog
platform
evalu
context
obtain
vaccin
base
inactiv
attenu
whole
viral
particl
could
challeng
find
right
condit
viru
amplif
viru
yield
dedic
cell
cultur
system
could
also
repres
limit
concomitantli
vaccin
develop
inactiv
viru
particl
also
interest
test
real
serolog
screen
neutral
antibodi
evid
product
wellcharacter
activ
viru
particl
also
interest
fundament
research
purpos
given
requir
speed
evalu
use
lcmsm
tool
guid
optimis
condit
whole
viral
particl
antigen
product
result
present
demonstr
potenti
pipelin
profil
viru
product
across
time
particular
analys
proteom
vero
cell
infect
two
differ
moi
possibl
monitor
chang
level
three
structur
protein
three
nonstructur
one
whilst
analys
could
detect
peptid
protein
e
like
lack
detect
accessori
protein
could
imput
differ
sampl
process
protocol
describ
favour
simplifi
step
speed
maintain
accuraci
deeper
analys
envisag
monitor
viru
homogen
differ
step
viral
product
permiss
condit
establish
remark
compar
profil
obtain
two
test
moi
profil
obtain
lower
moi
slightli
delay
henc
insight
regard
time
burst
abund
viral
level
overrepres
protein
describ
larger
varieti
peptid
interestingli
increas
protein
level
reli
increas
abund
set
peptid
new
sequenc
regist
late
time
point
suggest
absolut
quantif
viru
could
obtain
target
approach
follow
earli
detect
peptid
eventu
tandem
mass
spectrometri
proteotyp
could
also
propos
detect
virus
besid
profil
viru
product
mass
spectrometri
analysi
whole
cell
content
provid
insight
regard
cellular
respons
infect
notwithstand
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
detail
inform
avail
regard
viru
cell
entri
increas
understand
differ
step
replic
cycl
need
knowledg
one
first
attempt
character
cellular
respons
infect
vero
cell
interestingli
proteom
data
acquir
differ
cell
line
human
primat
order
defin
compar
proteom
common
mechan
cell
infect
mechan
specif
given
cell
line
analysi
proteom
data
suggest
substanti
tempor
remodel
host
proteom
show
pipelin
base
lcmsm
analysi
suitabl
tool
characteris
product
therefor
suggest
could
use
optimis
condit
viral
amplif
speed
initi
step
favour
later
develop
process
requir
care
evalu
effect
safeti
besid
peptid
inform
describ
provid
suffici
inform
enabl
target
analysi
open
possibl
use
mass
spectrometrybas
target
approach
evalu
critic
aspect
ie
qualiti
quantiti
differ
step
viru
purif
process
furthermor
character
chang
cellular
protein
network
upon
infect
provid
valuabl
insight
could
explor
guid
identif
drug
target
address
pandem
caus
anticip
workflow
could
success
appli
expedit
characteris
human
organonachip
organ
chip
microfluid
cultur
devic
use
obtain
insight
differ
step
viru
life
cycl
well
studi
human
diseas
pathogenesi
respons
infect
variant
addit
exist
novel
therapeut
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
lg
fg
op
lb
ja
conceptu
stud
design
fg
jcg
hb
sr
nb
perform
experi
lg
op
dg
fg
lb
ja
analys
data
gm
kc
sd
mar
gs
cf
ad
bab
cb
contribut
reagent
softwar
develop
lg
ja
draft
manuscript
author
read
approv
final
manuscript
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
figur
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
